| Literature DB >> 30775964 |
Anaïs Painset1,2, Jonas T Björkman3, Kristoffer Kiil3, Laurent Guillier4, Jean-François Mariet4, Benjamin Félix4, Corinne Amar1, Ovidiu Rotariu5, Sophie Roussel4, Francisco Perez-Reche6, Sylvain Brisse7, Alexandra Moura7, Marc Lecuit7, Ken Forbes8, Norval Strachan5, Kathie Grant1,2, Eva Møller-Nielsen3, Timothy J Dallman2,1.
Abstract
We present the LiSEQ (Listeria SEQuencing) project, funded by the European Food Safety Agency (EFSA) to compare Listeria monocytogenes isolates collected in the European Union from ready-to-eat foods, compartments along the food chain (e.g. food-producing animals, food-processing environments) and humans. In this article, we report the molecular characterization of a selection of this data set employing whole-genome sequencing analysis. We present an overview of the strain diversity observed in different sampled sources, and characterize the isolates based on their virulence and resistance profile. We integrate into our analysis the global L. monocytogenes genome collection described by Moura and colleagues in 2016 to assess the representativeness of the LiSEQ collection in the context of known L. monocytogenes strain diversity.Entities:
Keywords: Listeria monocytogenes; food; genetic diversity; human; phylogeny; whole-genome sequencing
Mesh:
Year: 2019 PMID: 30775964 PMCID: PMC6421348 DOI: 10.1099/mgen.0.000257
Source DB: PubMed Journal: Microb Genom ISSN: 2057-5858
Summary of the strains included in the LiSEQ study
| A | 7 | 29 | 35 | 71 | ||
| B | 4 | 28 | 68 | 31 | 43 | 174 |
| C | 35 | 83 | 32 | 35 | 25 | 210 |
| D | 4 | 20 | 24 | |||
| E | 6 | 6 | ||||
| F | 15 | 8 | 23 | |||
| G | 4 | 4 | 8 | |||
| H | 5 | 5 | ||||
| J | 10 | 10 | ||||
| K | 14 | 14 | ||||
| L | 54 | 54 | ||||
| M | 2 | 2 | ||||
| N | 9 | 9 | ||||
| P | 3 | 4 | 7 | |||
| Q | 33 | 100 | 23 | 156 | ||
| R | 4 | 4 | ||||
| S | 4 | 4 | ||||
| T | 4 | 20 | 5 | 29 | ||
| U | 62 | 62 | ||||
| V | 6 | 28 | 34 | |||
| 7 | 15 | 22 | ||||
| X | 38 | 34 | 35 | 32 | 139 | |
| Y | 8 | 20 | 28 | |||
| Z | 15 | 13 | 20 | 48 | ||
The CCs identified and the number of isolates by isolation context and listed in the strain selection information
Minor CCs (i.e. CCs with less than 10 isolates) included CC398, CC11, CC193, CC224, CC403, CC54, CC177, CC19, CC220, CC29, CC77, CC217, CC26, CC379, CC207, CC218, CC388, CC475, CC88, CC89, ST184, ST200, ST32, ST382, ST392, ST560, ST570, ST602, ST736, ST773 and ST839 (ordered according to occurrence).
| CC121 | II | 144 | 37 | 6 | 0 | 187 |
| CC9 | II | 81 | 15 | 14 | 0 | 110 |
| CC8 | II | 69 | 5 | 24 | 0 | 98 |
| CC1 | I | 10 | 4 | 50 | 8 | 72 |
| CC2 | I | 19 | 29 | 20 | 0 | 68 |
| CC101 | II | 10 | 41 | 16 | 0 | 67 |
| CC6 | I | 30 | 3 | 28 | 0 | 61 |
| CC155 | II | 32 | 1 | 8 | 13 | 54 |
| CC7 | II | 16 | 4 | 16 | 8 | 44 |
| CC14 | II | 13 | 2 | 9 | 13 | 37 |
| CC4 | I | 1 | 1 | 10 | 24 | 36 |
| CC87 | I | 10 | 0 | 4 | 19 | 33 |
| CC31 | II | 24 | 7 | 1 | 0 | 32 |
| CC3 | I | 18 | 7 | 6 | 0 | 31 |
| CC37 | II | 9 | 15 | 5 | 0 | 29 |
| CC204 | II | 17 | 3 | 1 | 0 | 21 |
| CC59 | I | 10 | 0 | 4 | 4 | 18 |
| CC5 | I | 7 | 6 | 4 | 0 | 17 |
| CC21 | II | 13 | 0 | 2 | 0 | 15 |
| CC20 | II | 8 | 2 | 2 | 0 | 12 |
| CC415 | II | 0 | 2 | 0 | 9 | 11 |
| CC18 | II | 0 | 6 | 4 | 0 | 10 |
| Minor CCs | LI=32 | 35 | 9 | 28 | 7 | 79 |
| 199 |
Fig. 1.(a) Core genome SNP maximum-likelihood phylogeny of genome sequences with the clades annotated by 7 loci MLST CC. (b) Minimum spanning tree of the isolates included in this study as described by 7 locus MLST. Each circle represents a single ST that is numbered on the tree. Major CCs defined by single locus variants are shaded in grey. The number of loci that differ between STs is labelled on the branches.
Fig. 2.Distribution of CCs in RTE food and from human clinical infections.
Fig. 3.Distribution of CCs from the three major food-product categories, including isolates from food-processing environments.
Fig. 4.Core SNP tree built with Parsnp showing lineages for . (a) The external ring shows the source of isolates. (b) The external ring describes the study origin of the isolates: orange, from the study by Moura et al. [7]; and blue, from LiSEQ.
Percentage of isolates in the study harbouring the assayed resistance genes
| Moura et al. [7 | ||
|---|---|---|
| 0.3 | 0.6 | |
| 0 | 0 | |
| 4.6 | 4.5 | |
| 4.5 | 4.5 | |
| 4.5 | 4.4 | |
| 0.8 | 0.3 | |
| 0.2 | 0.5 | |
| 14.9 | 18.7 | |
| 15.0 | 18.9 | |
| 0 | 0 |
Fig. 5.Scatter plot showing the proportion of each of the 115 putative virulence markers found in lineage I or lineage II (only significant results have been labelled).
Fig. 6.Scatter plot showing the proportion of each of the 115 putative virulence markers found in clinical or non-clinical isolates (only significant results have been labelled).